GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » European Medical Solutions (FRA:AS0) » Definitions » Institutional Ownership

European Medical Solutions (FRA:AS0) Institutional Ownership : 0.01% (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is European Medical Solutions Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, European Medical Solutions's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, European Medical Solutions's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, European Medical Solutions's Float Percentage Of Total Shares Outstanding is 0.00%.


European Medical Solutions Institutional Ownership Historical Data

The historical data trend for European Medical Solutions's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Medical Solutions Institutional Ownership Chart

European Medical Solutions Historical Data

The historical data trend for European Medical Solutions can be seen below:

2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31
Institutional Ownership 4.20 2.38 0.55 0.55 0.55 0.55 0.55 0.55 0.55 0.01

European Medical Solutions Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


European Medical Solutions (FRA:AS0) Business Description

Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

European Medical Solutions (FRA:AS0) Headlines

No Headlines